Literature DB >> 11849918

Evaluation of the human serum albumin column as a discovery screening tool for plasma protein binding.

Lisa Buchholz1, Chun-Hua Cai, Larry Andress, Adriaan Cleton, Joanne Brodfuehrer, Lucinda Cohen.   

Abstract

A total of 69 compounds with a variety of chemical structures were assayed using a human serum albumin column in combination with UV and mass spectrometric detection. A moderate correlation, R(2)=0.661, between the plasma protein binding, determined by traditional techniques of equilibrium dialysis or ultrafiltration, and chromatographic retention factor (k'/k'+1) was observed. Disparity between the regression line and numerous samples was observed across the entire range of plasma protein binding. Attempts to discriminate between compounds from the data set to achieve better correlation based physico-chemical properties were unsuccessful. Good agreement was observed for retention times obtained with UV detection with mobile phase containing phosphate buffer and mass spectrometric detection with mobile phase containing acetate buffer. Essentially identical data were obtained for compounds analyzed in singlet or cassette for minimally or highly bound (>90% bound) compounds. Analysis of cassettes containing compounds with plasma protein binding greater than 90% did not cause column overload, even at analyte concentrations up to 100 microg/ml. Diverse results were obtained when chromatographic retention was used to rank order various classes of compounds. Better correlation with ordering from known binding was obtained when a compound class contained a wide range of protein binding, in contrast to when compounds within a given class were all highly bound.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11849918     DOI: 10.1016/s0928-0987(01)00219-6

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  7 in total

1.  Characterization of solution-phase drug-protein interactions by ultrafast affinity extraction.

Authors:  Sandya R Beeram; Xiwei Zheng; Kyungah Suh; David S Hage
Journal:  Methods       Date:  2018-03-03       Impact factor: 3.608

2.  Identification and analysis of stereoselective drug interactions with low-density lipoprotein by high-performance affinity chromatography.

Authors:  Matthew R Sobansky; David S Hage
Journal:  Anal Bioanal Chem       Date:  2012-02-22       Impact factor: 4.142

Review 3.  Studies of metabolite-protein interactions: a review.

Authors:  Ryan Matsuda; Cong Bi; Jeanethe Anguizola; Matthew Sobansky; Elliott Rodriguez; John Vargas Badilla; Xiwei Zheng; Benjamin Hage; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2013-11-25       Impact factor: 3.205

4.  Analysis of drug interactions with high-density lipoprotein by high-performance affinity chromatography.

Authors:  Sike Chen; Matthew R Sobansky; David S Hage
Journal:  Anal Biochem       Date:  2009-10-13       Impact factor: 3.365

5.  Measurement of drug-protein dissociation rates by high-performance affinity chromatography and peak profiling.

Authors:  John E Schiel; Corey M Ohnmacht; David S Hage
Journal:  Anal Chem       Date:  2009-06-01       Impact factor: 6.986

6.  Studies of imipramine binding to human serum albumin by high-performance affinity chromatography.

Authors:  Michelle J Yoo; Quentin R Smith; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-03-10       Impact factor: 3.205

7.  Analysis of drug interactions with very low density lipoprotein by high-performance affinity chromatography.

Authors:  Matthew R Sobansky; David S Hage
Journal:  Anal Bioanal Chem       Date:  2014-08-08       Impact factor: 4.142

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.